Long-term survival of non-elderly patients with severe heart failure treated with angiotensin-converting enzyme inhibitors: Assessment of treatment with captopril and enalapril survival study (ACESS)

Circulation Journal

Volumn 66, Issue 10, 2002, Pages 886-890

  Huang, Chien Ming ^a   Young, Mason Shing ^a  

^a CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

ACE inhibitors; Congestive heart failure; Prognosis

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HEART DILATATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME; CAUSE OF DEATH; DRUG SCREENING; MIDDLE AGED; RETROSPECTIVE STUDY; SURVIVOR;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; CAUSE OF DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; ENALAPRIL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS; TREATMENT OUTCOME;

EID: 0036792448     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.886     Document Type: Article

References (27)

1. Hara Y, Hamada M, Shigematsu Y, Suzuki M, Kodama K, Kuwahara T, et al. Effect of beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor. Jpn Circ J 2000; 64: 365-369.
2. Inoko M, Fujita M, Nakae I, Tamaki S, Watanuki M, Hashimoto T, et al. Effect of angiotensin-converting enzyme inhibition on sympathetic tone in patients with mild to moderate heart failure. Jpn Circ J 2001; 65: 395-398.
3. Riegger GAJ. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure. Eur Heart J 1991; 12: 705-711.
4. Drexler H, Banhardt U, Meinertz T, Wollschlager H, Lehmann M, Just H. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. Circulation 1989; 79: 491-502.
5. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scadinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.
6. The SOLVD Investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293-302.
7. Pearson GJ, Cooke C, Simmons WK, Sketris I. Evaluation of the use of evidence-based angiotensin-converting enzyme inhibitor criteria for the treatment of congestive heart failure: Opportunities for pharmacists to improve patient outcomes. J Clin Pharm Ther 2001; 26: 351-361.
8. Pacher R, Stanek B, Glotbits S, Berger R, Hulsmann M, Wutte M, et al. Effects of two different enalapril dosages on clinical hemodynamic and neurohumoral response of patients with severe congestive heart failure. Eur Heart J 1996; 17: 1223-1232.
9. Berger R, Kuchling G, Frey B, Kozankly H, Pacher R, Staneck B. ACE inhibitor dosage at the time of listing predicts survival. J Heart Lung Transplant 2000; 19: 127-133.
10. Bach R, Zardini P. Long-acting angiotensin-converting enzyme inhibition: Once-daily lisionopril in mild-to-moderate heart failure (abstract). Am J Cardiol 1992; 70: 70C.
11. Packer M. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? J Am Coll Cardiol 1996; 28: 1323-1327.
12. Huang CM, Young MS. Predictors of short-term outcome in Chinese patients with ambulatory heart failure for heart transplantation with ejection fraction <25%. Jpn Heart J 2000; 41: 349-369.
13. Huang CM, Young MS. Transradial approach for diagnosis of cardiovascular disease in Taiwanese patients: Catheter selection, feasibility, complication and application. Acta Cardiol Sin 1999; 15: 9-16.
14. Swedberg K, Kjekshus J, Snapinn S, for the CONSENSUS investigators. Long-term survival in severe heart failure patients treated with enalapril. Eur Heart J 1999; 20: 163-169.
15. The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988; 259: 539-544.
16. Ader R, Chatterjee K, Portis T, Brundage B, Hiramtsu B, Parmley W. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by oral angiotensin-converting enzyme inhibitor. Circulation 1980; 61: 931-937.
17. Dicarlo L, Chatterjee K, Parmley WW, Swedberg K, Atherton B, Curran D, et al. Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure: Acute and chronic hemodynamic evaluation. J Am Coll Cardiol 1983; 2: 865-871.
18. Packer M, Poole-Wilson P, Armstrong P, et al. Comparative effects of low-dose versus high-dose lisinopril on survival and major events in chronic heart failure: The Assessment of Treatment with Lisinopril and Survival Study (ATLAS) (abstract). Eur Heart J 1998; 19(Suppl): 142.
19. Vagelos R, Yee G, Boyle M, et al. Failure of low but not high dose chronic enalapril therapy to suppress serum angiotensin converting enzyme (ACE) activity in heart failure. Am J Cardiol 1992; 19: 145A.
20. Pacher R, Glotbits S, Bergler-Klein J, Teufelsbauer H, Wutte M, Baumgartner W, et al. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages. Eur Heart J 1993; 14: 273-278.
21. Wollert KC, Studer R, von Bulow B, Drexler H. Survival after myocardial infarction in the rat: Role of tissue angiotensin-converting enzyme inhibition. Circulation 1994; 90: 2457-2467.
22. Dirksen M, Pijls N, Duijst P, Boerrma J. Enalapril and captopril in severe chronic heart failure. Drug Invest 1991; 3: 25-33.
23. Packer M, Lee WH, Yushak M, Medina N. Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med 1986; 315: 847-853.
24. The NETWORK Investigators. Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. Eur Heart J 1998; 19: 481-489.
25. Pouleur H, Rousseau MF, Oakley C, Ryden L. Difference in mortality between patients treated with captopril or enalapril in the xamoterol in severe heart failure study. Am J Cardiol 1991; 3: 25-33.
26. White CM. Pharmacological, pharmacokinetic and therapeutic differences among ACE inhibitors. Pharmacotherapy 1998; 18: 588-599.
27. Komuro I. Molecular mechanism of mechanical stress-induced cardiac hypertrophy. Jpn Heart J 2000; 41: 117-129.